ORPHA:912
Zellweger syndrome
Also known as: Cerebrohepatorenal syndrome · Severe PBD-ZSD · Severe peroxisome biogenesis disorder-Zellweger spectrum disorder · ZS
Publications
3,263
Trials
4
Interventional, condition-specific
Researchers
1,098
Distinct authors in sample
Gene link
—
Readiness
4/6
Stages with a signal
Clinical definition (Orphanet)
A rare peroxisome biogenesis disorder (the most severe variant of Peroxisome biogenesis disorder spectrum) characterized by neuronal migration defects in the brain, craniofacial features, profound , , and liver dysfunction.
How rare: How common this is has not been clearly measured.
Cross-references
Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.
- MONDO:0019609
- MeSH:D015211
- UMLS:C0043459
- NCIT:C85239
Additional Mondo synonyms (3)
ZWS · Zellweger spectrum disorders · cerebrohepatorenal syndrome
Research stages
Trial readiness signals
Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”
4/6 stages with a signal
An interventional trial matched this condition name on ClinicalTrials.gov — see trials below.
- Gene identifiedNot found
No GenCC disease–gene assertion in this build
- LiteraturePresent
3,263 matched papers (1,352 in last 10 years) Source
- Phenotype characterisedPresent
779 HPO annotations (e.g. EEG abnormality; Skeletal dysplasia; Micrognathia) Source
- Animal modelPresent
8 genotype models (Danio rerio, Mus musculus) Source
- Orphan designationNot found
No FDA or EMA orphan-drug designation matched this disease via UMLS or preferred name Source
- Interventional trialPresent
4 matched on ClinicalTrials.gov
Biology
Genes and phenotypes
Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.
Do we know what causes it?
Not yet — the cause hasn't been pinned down in GenCC.
No strong gene–disease assertion joined for this Orphanet entity.
Phenotypes (Monarch / HPO)
779
Associated phenotypes · MONDO:0019609
- EEG abnormality
- Skeletal dysplasia
- Micrognathia
- Sensorineural hearing impairment
- Premature birth
Showing 5 of 779 — open Monarch for the full list.
Animal models (Monarch / Alliance)
8
Model associations linked to this Mondo ID
- pex2gf2/gf2 (RW)·ZFIN:ZDB-FISH-220715-9·Danio rerio
- pex1lux4/lux4 (AB)·ZFIN:ZDB-FISH-251218-1·Danio rerio
- pex2gf1/gf1 (RW)·ZFIN:ZDB-FISH-220715-8·Danio rerio
- Pex11btm1Sjg/Pex11btm1Sjg [background:] B6.129-Pex11btm1Sjg·MGI:5307126·Mus musculus
- Pex11btm1Sjg/Pex11b+ [background:] B6.129-Pex11btm1Sjg·MGI:5307125·Mus musculus
- Pex1tm1.1Sjms/Pex1tm1.1Sjms [background:] involves: 129 * C57BL/6N·MGI:5571189·Mus musculus
- Pex1tm1.1Hrw/Pex1tm1.1Hrw [background:] involves: C57BL/6NTac·MGI:6390207·Mus musculus
- Pex11btm1Sjg/Pex11btm1Sjg [background:] involves: 129S1/Sv * 129X1/SvJ * C57BL/6·MGI:3042895·Mus musculus
Monarch fetch 2026-07-29
Therapies
Designations, candidates, and chemicals
FDA OOPD and EMA orphan designations, Open Targets clinical candidates, and CTD chemical associations via MyDisease.info. These never change the interventional-trial headline.
Orphan designation (FDA · EMA)
No designation matched this disease via UMLS or preferred name on the FDA OOPD mirror or EMA orphan register. Absence here is not proof that none exists under another wording.
CTD chemicals (MyDisease.info)
1 associated chemical · 18 pathways. Therapeutic evidence is listed first when present — not a treatment recommendation.
- Leukotriene B4 · marker/mechanism
Pathways: Primary bile acid biosynthesis; Metabolic pathways; ABC transporters; Peroxisome; Bile acid biosynthesis, cholesterol => cholate/chenodeoxycholate; ABC transporters in lipid homeostasis; Metabolism; Synthesis of bile acids and bile salts
Literature
Is anyone studying this?
3,263
3,263 papers have been published on this condition. That is a real research literature — still far smaller than common diseases (breast cancer: over 700,000 papers). Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=3967) is 59.
3,263 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 59 (publications denominator n=3967).
1,352 in the last 10 years · low confidence
Phrase hits: 3,263 · MeSH hits: 0
Who's working on it?
1,098
Distinct author names in 200 sampled papers — named people below.
Who's working on it?
People publishing on this condition (sampled Europe PMC records). Affiliation is the most recent found in that sample.
- 01Wanders RJA9 papers · 2025
Laboratory Genetic Metabolic Diseases, Department of Clinical Chemistry, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Papers in Europe PMC - 02Waterham HR8 papers · 2024
Laboratory Genetic Metabolic Diseases, Department of Clinical Chemistry, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Papers in Europe PMC - 03Braverman NE7 papers · 2025
Department of Human Genetics and Pediatrics, McGill University Health Centre, Montreal, Canada.
Papers in Europe PMC - 04Wangler MF7 papers · 2025
Department of Molecular and Human Genetics, Baylor College of Medicine, Duncan Neurological Research Institute, DNRI-1050, Houston, TX 77030, USA. Electronic address: michael.wangler@bcm.edu.
Papers in Europe PMC - 05Braverman N6 papers · 2025
Child Health and Human Development Axis, Research Institute of the McGill University Health Centre, Montréal, Québec, Canada; Department of Human Genetics, McGill University, Montréal, Québec, Canada. Electronic address: nancy.braverman@mcgill.ca.
Papers in Europe PMC - 06Ferdinandusse S6 papers · 2023
Laboratory Genetic Metabolic Diseases, Department of Clinical Chemistry, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Papers in Europe PMC - 07Klouwer FCC6 papers · 2024
Department of Paediatric Neurology/Emma Children's Hospital, Amsterdam University Medical Centers, Amsterdam, The Netherlands.
Papers in Europe PMC - 08Poll-The BT5 papers · 2019
Department of Pediatric Neurology, Emma Children's Hospital, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Papers in Europe PMC - 09Setchell KDR5 papers · 2025
Pathology and Laboratory Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
Papers in Europe PMC - 10Vaz FM5 papers · 2024
Laboratory Genetic Metabolic Diseases, Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands. f.m.vaz@amc.uva.nl.
Papers in Europe PMC
Clinical research
Is a treatment being tested?
4
interventional trials for this specific condition
4 interventional trials matched this specific condition name; none in our sample are currently recruiting.
Data as of 11 September 2026
4 interventional trials — more than 77.2% of diseases in the trials denominator have none at all (5501 of 7126; this disease is at the 88.1th percentile).
low confidence · 88.1th percentile (trials denominator)
Recruiting interventional trials
From the matched ClinicalTrials.gov set
4 interventional trials matched after quoted-phrase search and title/condition post-filter.
No currently recruiting studies in the matched set. Open the same search on ClinicalTrials.gov.
Observational and natural-history studies
3 observational studies match this condition. These do not test a treatment and are not counted in the interventional-trial headline, but they are genuine research: natural-history work often defines the endpoints needed for a future rare-disease trial, and families may be able to enroll.
Recruiting or not-yet-recruiting
- NCT03047369·RECRUITING·The Myelin Disorders Biorepository Project
Not reviewed·Conditions: Leukodystrophy · White Matter Disease · Leukoencephalopathies · 4H Syndrome·Matched via name phrase
Other registries (secondary)
Broader net from EU CTIS, ISRCTN, and ICTRP when available — deduped against ClinicalTrials.gov IDs already counted above. Dual-model LLM relevance gates what we keep. These rows are not added to the interventional headline.
raw 0 · after dedupe 0 · already on CT.gov 0 · kept 0 · parent 0 · uncertain 0 · dropped 0 · fetched 2026-07-29
Source notes: ictrp: Error: ICTRP public search unavailable (WHO portal is SPA-only; SOAP needs partnership). Tried: https://apps.who.int/tri
No secondary-registry studies passed dual-model relevance for this condition name (after dedupe).
Where to find support
Condition-specific patient organisations, when Orphanet lists them, are on the disease’s Orphanet page. We also link umbrella groups that support undiagnosed and ultra-rare families.
Orphanet entry for Zellweger syndrome — check Associations / patient organisations on that page.
India — NPRD
Last verified 2026-07-26This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.
Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.
How we counted this
Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.
"Zellweger syndrome" OR "Cerebrohepatorenal syndrome" OR "Severe PBD-ZSD" OR "Severe peroxisome biogenesis disorder-Zellweger spectrum disorder" OR "Zellweger spectrum disorders"
ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):
"Zellweger syndrome" OR "Cerebrohepatorenal syndrome" OR "Severe PBD-ZSD" OR "Severe peroxisome biogenesis disorder-Zellweger spectrum disorder" OR "Zellweger spectrum disorders"
Interventional trials matched via: phrase (mesh = registered under a MeSH descriptor no name phrase would catch; recall-expansion = gene / selected parent terms used only for trials).
Study-type breakdown: 4 interventional · 3 observational · 0 expanded access. Only interventional studies enter the trial headline.
Query health: ok — strategies attempted: phrase; with hits: phrase
Run this search on ClinicalTrials.gov
Synonyms dropped by stoplist: ZS; ZWS
Confidence reasoning
- Preferred label is short or not clearly distinctive
- 2 synonym(s) dropped by stoplist (may under-count)
- No label/synonym collisions with other diseases in this corpus
Ingested 2026-07-26T15:53:54.918Z
